140 research outputs found

    Model catalysts synthesized by the di-block copolymer inverse micelle method: insights on nanoparticle formation and network stability within the environmental TEM

    Get PDF
    MICROSCOPIE+MEME+FCA:EEH:LBU:TEPInternational audienceThe di-block copolymer inverse micelle method, where an amphiphilic di-block copolymer dissolved in toluene creates a system of inverse micelles, is a rather simple method to obtain well controlled supported metallic nanoparticles once the micelle core is charged with metallic salts. Supported metallic catalysts can be obtained in this way on both flat (model catalysts) and powder (realistic catalysts) supports [1]. Our main interest deals with applications of bimetallic catalyst systems that we investigate from extended catalytic surfaces [2] to realistic catalysts [3]; the idea being to isolate and understand the role of important physico-chemical parameters on the catalytic behaviour of these systems in the shape of model catalytic surfaces and try to extrapolate them to realistic catalysts. This is very important for the controlled design of catalysts with specific properties. In this way we can, not only spend less active material (often rare and expensive), but also avoid unnecessary poisoning while keeping high activity (stability) and finely tune the selectivity to avoid deleterious unwanted products; these are important points to be able to achieve environmentally friendly and sustainable catalytic processes. Self-organized nanoparticles on flat surfaces is an intermediate configuration between extended catalytic surfaces and realistic catalysts and a necessary step to better extrapolate results between model and realistic systems. We have thus extended the di-block copolymer method to the synthesis of bimetallic catalysts [4]. In our presentation we will deal with a PdAu system, obtained from a PS-b-P2VP copolymer micellar solution that we transfer by spin-coating to a surface of a SiNx eletron-transparent films on dedicated microchips than are heated in Wildfire sample holder (DENS Solutions) within an objective lens aberration-corrected environmental TEM (Titan ETEM G2 80-300 kV from ThermoFisher Scientific) so that we can study in situ the behaviour of such a system in variable temperature and gas pressure. We observed the formation of the individual particles from the seeds within the core of the micelles in the presence of oxygen in variable temperature; sintering of the seeds within the micelle cores starts at 350°C and is completed at 500°C, temperatures that correspond, respectively, to the onset of the copolymer decomposition and to its quasi-completed decomposition [5]. We also observed that the network of nanoparticles is stable under oxygen up to 900°C and that, above this temperature, the network is modified only by the decomposition of the nanoparticles (when we approach their melting point).The authors acknowledge the French Microscopy and Atom probe network (METSA) and the Consortium Lyon – St-Etienne de Microscopie (CLYM) for supporting this work.References:[1] B. Roldan Cuenya, Accounts of Chemical Research 46 (2013) 1682.[2] MC Saint-Lager et al., ACS Catalysis 9 (2019) 4448.[2] B. Pongthawornsakun et al., Applied Catalysis A: General 549 (2018) 1.[4] E. Ehret et al., Nanoscale 7 (2015) 13239.[5] T. Orhan Lekesiz et al., Journal of Analytical and Applied Pyrolysis 106 (2014) 81

    Bimetallic PdAg nanoparticle arrays from monolayer films of diblock copolymer micelles

    Get PDF
    International audienceThe self-assembly technique provides a highly efficient route to generate well-ordered structures on a nanometer scale. In this paper, well-ordered arrays of PdAg alloy nanoparticles on flat substrates with narrow distributions of particle size (6-7 nm) and interparticle spacing (about 60 nm) were synthesized by the block copolymer micelle approach. A home-made PS-b-P4VP diblock copolymer was prepared to obtain a micellar structure in toluene. Pd and Ag salts were then successfully loaded in the micellar core of the PS-b-P4VP copolymer. A self-assembled monolayer of the loaded micelles was obtained by dipping the flat substrate in the solution. At this stage, the core of the micelles was still loaded with the metal precursor rather than with a metal. Physical and chemical reducing methods were used to reduce the metal salts embedded in the P4VP core into PdAg nanoparticles. HRTEM and EDX indicated that Pd-rich PdAg alloy nanoparticles were synthesized by chemical or physical reduction; UV-visible spectroscopy observations confirmed that metallic PdAg nanoparticles were quickly formed after chemical reduction; XPS measurements revealed that the PdAg alloy nanoparticles were in a metallic state after a short time of exposure to O-2 plasma and after hydrazine reduction

    Cation distribution in manganese cobaltite spinels Co3−xMnxO4 (0 ≤ x ≤ 1) determined by thermal analysis

    Get PDF
    Thermogravimetric analysis was used in order to study the reduction in air of submicronic powders of Co3−x Mn x O4 spinels, with 0 ≤ x ≤ 1. For x = 0 (i.e. Co3O4), cation reduction occurred in a single step. It involved the CoIII ions at the octahedral sites, which were reduced to Co2+ on producing CoO. For 0 < x ≤ 1, the reduction occurred in two stages at increasing temperature with increasing amounts of manganese. The first step corresponded to the reduction of octahedral CoIII ions and the second was attributed to the reduction of octahedral Mn4+ ions to Mn3+. From the individual weight losses and the electrical neutrality of the lattice, the CoIII and Mn4+ ion concentrations were calculated. The distribution of cobalt and manganese ions present on each crystallographic site of the spinel was determined. In contrast to most previous studies that took into account either CoIII and Mn3+ or Co2+, CoIII and Mn4+ only, our thermal analysis study showed that Co2+/CoIII and Mn3+/Mn4+ pairs occupy the octahedral sites. These results were used to explain the resistivity measurements carried out on dense ceramics prepared from our powders sintered at low temperature (700–750 °C) in a Spark Plasma Sintering apparatus

    Multi-catheter cryotherapy for the treatment of resistant accessory pathways.

    Get PDF
    OBJECTIVE: To investigate the utility of simultaneous multi-catheter cryotherapy for the treatment of APs that were previously resistant to standard radiofrequency (RF) catheter ablation. BACKGROUND: Catheter ablation is established in the treatment of accessory pathways (AP), with high rates of permanent procedural success with a single attempt. However, there are still instances of acute procedural failure and AP recurrences with standard RF and cryotherapy methods. METHODS: Seven consecutive cases of pre-excitation syndromes with prior failed RF catheter ablation had the novel treatment. Cryotherapy was delivered using two 8 mm tip focal cryoablation catheters (Freezor® Max, Medtronic, Minneapolis, Minnesota, USA). RESULTS: Accessory pathway localisation was septal in 5 cases, left posterolateral in 1, right lateral in 1. In all cases, ablation of the AP was acutely successful with no procedural complications. Median procedure and fluoroscopy durations were 199 and 35 min, sequentially. Median Procedure duration fell significantly in the second half of series (174 min) compared to the first half (233 min, P = 0.05). One patient had evidence of a recurring AP conduction with pre-excitation at 5-week follow up. After a median follow up of 66.8+-6.5 months, 6 out of 7 patients remained asymptomatic and free of pre-excitation. CONCLUSION: Simultaneous multi-catheter cryotherapy is feasible, safe and can provide definitive cure of accessory pathways that were previously resistant to standard radiofrequency ablation. Further study is required in the assessment of this novel form of advanced cryotherapy to treat complex and resistant arrhythmias

    Exclusively cephalic venous access for cardiac resynchronisation: A prospective multi-centre evaluation.

    Get PDF
    BACKGROUND: Small series has shown that cardiac resynchronisation therapy (CRT) can be achieved in a majority of patients using exclusively cephalic venous access. We sought to determine whether this method is suitable for widespread use. METHODS: A group of 19 operators including 11 trainees in three pacing centres attempted to use cephalic access alone for all CRT device implants over a period of 8 years. The access route for each lead, the procedure outcome, duration, and complications were collected prospectively. Data were also collected for 105 consecutive CRT device implants performed by experienced operators not using the exclusively cephalic method. RESULTS: A new implantation of a CRT device using exclusively cephalic venous access was attempted in 1091 patients (73.6% male, aged 73 ± 12 years). Implantation was achieved using cephalic venous access alone in 801 cases (73.4%) and using a combination of cephalic and other access in a further 180 (16.5%). Cephalic access was used for 2468 of 3132 leads implanted (78.8%). Compared to a non-cephalic reference group, complications occurred less frequently (69/1091 vs 12/105; P = .0468), and there were no pneumothoraces with cephalic implants. Procedure and fluoroscopy duration were shorter (procedure duration 118 ± 45 vs 144 ± 39 minutes, P < .0001; fluoroscopy duration 15.7 ± 12.9 vs 22.8 ± 12.2 minutes, P < .0001). CONCLUSIONS: CRT devices can be implanted using cephalic access alone in a substantial majority of cases. This approach is safe and efficient

    Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands

    Get PDF
    The design of dualsteric/bitopic agents as single chemical entities able to simultaneously interact with both the orthosteric and an allosteric binding site represents a novel approach in medicinal chemistry. Biased dualsteric/bitopic agents could enhance certain signaling pathways while diminishing the others that cause unwanted side effects. We have designed, synthesized, and functionally characterized the first CB2R heterobivalent bitopic ligands. In contrast to the parent orthosteric compound, our bitopic ligands selectively target CB2R versus CB1R and show a functional selectivity for the cAMP signaling pathway versus βarrestin2 recruitment. Moreover, the most promising bitopic ligand FD-22a displayed anti-inflammatory activity in a human microglial cell inflammatory model and antinociceptive activity in vivo in an experimental mouse model of neuropathic pain. Finally, computational studies clarified the binding mode of these compounds inside the CB2R, further confirming their bitopic nature

    Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the swiss cohort

    Full text link
    BACKGROUND AND AIMS Stereotactic arrhythmia radioablation (STAR) has been recently introduced for the management of therapy-refractory ventricular tachycardia (VT). VT recurrences have been reported after STAR but the mechanisms remain largely unknown. We analyzed recurrences in our patients after STAR. METHODS From 09.2017 to 01.2020, 20 patients (68±8y, LVEF 37±15%) suffering from refractory VT were enrolled, 16/20 with a history of at least 1 electrical storm. Before STAR, an invasive electro-anatomical mapping (Carto3) of the VT substrate was performed. A mean dose of 23±2Gy was delivered to the planning target volume (PTV). RESULTS The median ablation volume was 26 ml (range 14-115) and involved the interventricular septum in 75% of patients. During the first 6 months after STAR, VT burden decreased by 92% (median value, from 108 to 10 VT/semester). After a median follow-up of 25 months, 12/20 (60%) developed a recurrence and underwent a redo ablation. VT recurrence was located in proximity of the treated substrate in 9 cases, remote from the PTV in 3 cases and involved a larger substrate over ≥3 LV segments in 2 cases. No recurrences occurred inside the PTV. Voltage measurements showed a significant decrease in both bipolar and unipolar signal amplitude after STAR. CONCLUSION STAR is a new tool available for the treatment of VT, allowing for a significant reduction of VT burden. VT recurrences are common during follow-up, but no recurrences were observed inside the PTV. Local efficacy was supported by a significant decrease in both bipolar and unipolar signal amplitude
    corecore